Evidence map›Paper›PMID 31872510›Full record

ReviewNutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition2020

Mechanisms of Parenteral Nutrition-Associated Liver and Gut Injury.

Himani Madnawat, Adam L Welu, Ester J Gilbert, Derian B Taylor, Sonali Jain, Chandrashekhara Manithody, Keith Blomenkamp, Ajay K Jain

Abstract readReview
In one paragraph

Review in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Enteral versus parenteral nutrition in auto-HCT: a randomized controlled trial on clinical outcomes and gut microbiome dynamics.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  2. Trial
  3. Trial
  4. Necrotizing enterocolitis.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Farnesoid X Receptor Agonist Tropifexor Improves Intestinal Defense Response and Epithelial Barrier Function in Neonatal Piglets Receiving Parenteral Nutrition.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Risk Factors forAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. A review of chyme reinfusion: new tech solutions for age old problems.Journal of the Royal Society of New Zealand · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Himani MadnawatDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0003-0682-656X
Adam L WeluDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Ester J GilbertDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Derian B TaylorDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Sonali JainDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Chandrashekhara ManithodyDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Keith BlomenkampDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.
Ajay K JainDepartment of Pediatrics, St. Louis University School of Medicine, Cardinal Glennon Children's Medical Center, St. Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-9420-5722

Funding

Role of the bile acid activated receptors FXR and TGR5 in Total Parenteral Nutrition associated hepatic and gut diseaseK08DK098623 · NIDDK · SAINT LOUIS UNIVERSITY · PI JAIN, AJAY K. · 2016 to 2021
$821k
Enhancing Health Care Access with Cellular TechnologyR03EB015955 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI JAIN, SANJAY · 2015 to 2016
$256k
Role of gut microbiota in total parenteral nutrition associated injuryR03DK121046 · NIDDK · SAINT LOUIS UNIVERSITY · PI JAIN, AJAY K. · 2019 to 2020
$227k
A.S.P.E.N. 2017 Research Workshop (RW) Gastric Bypass: Role of the GutR13DK109671 · NIDDK · AMERICAN SOCIETY/PARENT & ENTERAL NUTRIT · PI JAIN, AJAY K. · 2017 to 2017
$10k
NIBIB NIH HHS R03 EB015955NIDDK NIH HHS K08 DK098623NIDDK NIH HHS K08DK098623NIDDK NIH HHS R03 DK121046NIDDK NIH HHS R03EB015955-01NIDDK NIH HHS R13 DK109671NIDDK NIH HHS R13DK109671-01
6 · The paper itself

Abstract

Parenteral nutrition (PN) has revolutionized the care of patients with intestinal failure by providing nutrition intravenously. Worldwide, PN remains a standard tool of nutrition delivery in neonatal, pediatric, and adult patients. Though the benefits are evident, patients receiving PN can suffer serious cholestasis due to lack of enteral feeding and sometimes have fatal complications from liver injury and gut atrophy, including PN-associated liver disease or intestinal failure-associated liver disease. Recent studies into gut-systemic cross talk via the bile acid-regulated farnesoid X receptor (FXR)-fibroblast growth factor 19 (FGF19) axis, gut microbial control of the TGR5-glucagon-like peptide (GLP) axis, sepsis, and role of prematurity of hepatobiliary receptors are greatly broadening our understanding of PN-associated injury. It has also been shown that the composition of ω-6/ω-3 polyunsaturated fatty acids given parenterally as lipid emulsions can variably drive damage to hepatocytes and cell integrity. This manuscript reviews the mechanisms for the multifactorial pathogenesis of liver disease and gut injury with PN and discusses novel ameliorative strategies.

Indexed as

CholestasisEnteral NutritionFatty Acids, Omega-3Fibroblast Growth FactorsGastrointestinal DiseasesGastrointestinal MicrobiomeHumansIntestinal DiseasesIntestinesLiverLiver DiseasesParenteral NutritionFatty Acids, Omega-3FGF19 protein, humanFibroblast Growth Factorsliver diseasesmicrobiomenutrition supportparenteral nutritionsepsisshort bowel syndrome

Identifiers

PMID31872510
PMCPMC7014933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.